FAA antidepressant pilot certification has never been a simple process. For years, the math on antidepressants and flying was brutal. Start a medication, ground yourself for six months, then begin the special issuance process. Change your dose, reset the clock. The waiting period alone kept a lot of pilots from seeking treatment they needed, which was exactly the wrong outcome for everyone involved.
In December 2025, the FAA cut that waiting period from six months to three. It’s the most significant change to the antidepressant certification pathway in years, and if you’ve been sitting on a treatment decision because of the timeline, it’s worth understanding what actually changed and what the process looks like now.
What Changed for Certification
The FAA’s Antidepressant Protocol, formerly called the SSRI Protocol, now requires only three months of stability on a single, stable dose before you can complete the required testing and submit for special issuance. That applies to pilots starting a new medication and pilots who change their dose. Previously both situations required six months before you could move forward.
Three months is still a meaningful commitment. You’re grounded during that window. But cutting the timeline in half removes one of the biggest deterrents pilots cited for avoiding mental health treatment, and that was the point.
FAA Approved Medications
The list has expanded considerably from the original four SSRIs. The FAA now accepts the following under the Antidepressant Protocol:
The original four SSRIs: fluoxetine (Prozac), sertraline (Zoloft), citalopram (Celexa), and escitalopram (Lexapro).
Added in 2023: bupropion extended-release (Wellbutrin XL), a dopamine/norepinephrine reuptake inhibitor.
Added in 2024: duloxetine (Cymbalta), venlafaxine (Effexor), and desvenlafaxine (Pristiq).
Added in 2025: vilazodone (Viibryd).
If your medication isn’t on that list, there is no special issuance pathway for it under this protocol. That includes paroxetine (Paxil), fluvoxamine (Luvox), benzodiazepines, antipsychotics, mood stabilizers, and lithium. The medication matters before you start treatment, not after. If you’re a pilot considering starting an antidepressant and you want to preserve your path to certification, confirm the medication is on the approved list before you fill the prescription.
Process Updates
Qualifying for special issuance under the Antidepressant Protocol isn’t just a matter of waiting three months and showing up. There’s a defined sequence of evaluations.
First, three months of documented stability on your current medication and dose. No changes, no gaps, documented by your treating physician throughout.
Second, a comprehensive evaluation by a board-certified psychiatrist written to FAA specifications. If your treating physician is already a board-certified psychiatrist, they handle both the treating physician documentation and the psychiatric evaluation.
Third, a neuropsychological evaluation including the CogScreen-AE, which is the FAA’s standard cognitive screening tool for pilots on psychoactive medication. It measures attention, processing speed, and working memory under conditions that approximate the cognitive demands of flight. The FAA uses it to confirm the medication isn’t producing side effects that would affect cockpit performance.
Fourth, all of that documentation goes to a HIMS AME who reviews the complete package, completes the required HIMS AME checklist, and submits the full packet to AMCD in Oklahoma City within 14 days of your exam.
If you’re a commercial pilot, a chief pilot report is also required.
Potential Complications
The most common reason pilots get delayed when they should qualify is arriving unprepared. Incomplete documentation, a medication not on the approved list, a dose change during the three-month window, or a psychiatrist letter that doesn’t address what the FAA actually needs to see. AMCD will come back with a request for more information, the clock effectively resets on that piece, and what should have been a clean submission turns into a months-long back-and-forth.
The other thing that derails pilots is stopping the medication without a plan. If you decide to discontinue and want to pursue regular issuance instead, you need to be off the medication for a minimum of 60 days with a favorable report from your treating physician confirming stable mood and no aeromedically significant side effects. Stopping cold and then trying to re-start later is worse, not better. If you restart after stopping, the waiting period begins again.
Don’t make medication decisions based on what you think will make the FAA happy. Make them based on what’s medically appropriate, and then work with a HIMS AME to navigate the certification pathway from there.
The Bottom Line
If you’ve been avoiding treatment because you didn’t understand what FAA antidepressant pilot certification actually requires, the December 2025 change is worth a second look. Three months is a real commitment and the process is involved, but it’s navigable with the right preparation and the right AME in your corner.
Kansas Aviation Medicine handles antidepressant protocol cases as part of its HIMS practice. If you want to understand where you stand before making any decisions, start with a confidential aeromedical consultation. Book here or call (785) 706-4327.
